文献速递胃肠外科围术期管理与 ERAS

原发胃肿瘤基因组特征与根治术后远处复发模式的关系

Primary Tumor Genomics and Patterns of Distant Recurrence in Resected Gastric Cancer.
PubMed 文献 · JAMA Surg · 2026-08-05

该单中心队列研究纳入2010至2024年接受根治性切除的胃腺癌(I–III期)患者,对原发肿瘤行MSK-IMPACT靶向测序,分析无病生存及转移模式与基因组改变的关联。中位随访可评估的377例中179例复发,KRAS与PIK3CA改变独立关联更差无病生存;血行复发肿瘤染色体不稳定性更高,骨转移原发瘤基因组更稳定且Lauren弥漫型多见。

要点

  • KRAS改变与更差无病生存独立相关(HR 1.54,95%CI 1.04-2.28,P=0.03)。
  • 血行复发者原发瘤染色体不稳定性及全基因组倍增高于腹膜复发者。

核心结论

  • 原发胃肿瘤的基因组改变与根治术后无病生存及复发转移模式相关,或可用于术后监测与围术期治疗决策的个体化。

研究设计与样本

  • 单中心队列研究,纳入2010至2024年在学术四级转诊中心接受根治性切除且切缘阴性、原发瘤行MSK-IMPACT靶向测序的胃腺癌(I–III期)患者。
  • 主分析排除无病生存但随访不足2年的患者,最终分析377例,中位年龄64(IQR 55-71)岁,女性113例(30%)、男性264例(70%)。

主要发现

  • 377例中179例复发、198例无病生存。

临床怎么用

  • 对根治性切除的胃腺癌可考虑原发瘤靶向测序,KRAS或PIK3CA改变者术后复发风险更高,宜加强监测。
  • 复发模式与基因组特征相关,血行转移尤其骨转移的原发瘤基因组特征不同,或有助于个体化随访策略。

局限性

  • 单中心回顾性队列设计,结论外推需谨慎。
  • 主分析排除随访不足2年的无病生存患者,可能引入选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with gastric cancer face substantial risk of recurrence after surgical resection. Molecular profiling of primary tumors may improve risk stratification to guide postoperative management. OBJECTIVE: To identify genomic features of primary gastric tumors associated with disease recurrence and patterns of metastatic spread. DESIGN, SETTING, AND PARTICIPANTS: This single-center cohort study took place at an academic quaternary referral center and included patients who underwent curative-intent resection of gastric adenocarcinoma from 2010 to 2024. Patients were classified by recurrence status and pattern of metastatic spread. Patients with gastric cancer (stages I to III) who underwent a margin-negative resection and had genomic sequencing of their primary tumor were included. Primary analysis excluded patients who had no evidence of disease with less than 2 years of follow-up. These data were analyzed from June 2025 through March 2026. EXPOSURES: Primary tumor specimens were sequenced using a targeted panel of cancer-associated genes (MSK-IMPACT). MAIN OUTCOMES AND MEASURES: Correlation of disease-free survival and patterns of metastatic spread (hematogenous, peritoneal, or lymphatic) with primary tumor genomic profile. RESULTS: Among 438 patients who underwent complete oncologic resection, 377 had sufficient clinical follow-up or developed recurrence (median [IQR] age, 64 [55-71] years; 113 female [30%] and 264 male [70%]). Recurrence was identified in 179 patients, whereas 198 patients had no evidence of disease. In a multivariable analysis, alterations in KRAS (hazard ratio [HR], 1.54; 95% CI, 1.04-2.28; P = .03) and PIK3CA (HR, 2.15; 95% CI, 1.25-3.69; P = .006) were independently associated with worse disease-free survival. Tumors of patients with hematogenous recurrence had greater chromosomal instability (fraction genome altered, 0.11 vs 0.03; P = .001), whole-genome duplication (47% vs 15%; P = .02), and more frequent alterations of genes modulating cell cycle regulation (39% vs 6%; P < .001) compared with peritoneal recurrence. Bone metastasis arose from more genomically stable primary tumors (fraction genome altered, 0.005 vs 0.114; P < .001) and tumors with Lauren diffuse-type histology (36% vs 3%; P < .001) compared with other sites of hematogenous spread. CONCLUSIONS AND RELEVANCE: This study identifies genomic alterations associated with disease-free survival and patterns of recurrence after resection of gastric cancer. These clinicogenomic risk factors may personalize postoperative surveillance strategies and inform perioperative treatment decisions.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Coffey MR, Xu J, Atri P, et al. Primary Tumor Genomics and Patterns of Distant Recurrence in Resected Gastric Cancer. JAMA Surg. 2026. PMID: 42555007. doi:10.1001/jamasurg.2026.3270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。